Immunomodulatory and cytotoxic activities of euphol
This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines. CP and AP we...
Gespeichert in:
Veröffentlicht in: | Life sciences (1973) 2021-09, Vol.280, p.119700-119700, Article 119700 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 119700 |
---|---|
container_issue | |
container_start_page | 119700 |
container_title | Life sciences (1973) |
container_volume | 280 |
creator | de Oliveira, Thais Latansio Bavia, Lorena Fontana, Pâmela Dias Cruz, Luiza Stolz Paludo, Katia Sabrina Crisma, Amanda Rabello Messias-Reason, Iara Jose Beltrame, Flávio Luís |
description | This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines.
CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining.
Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines.
Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment.
[Display omitted]
•Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases. |
doi_str_mv | 10.1016/j.lfs.2021.119700 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2540520219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002432052100686X</els_id><sourcerecordid>2540520219</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</originalsourceid><addsrcrecordid>eNp9kE1LxDAURYMoOI7-AHcFN25aX9KmaXEl4sfAgBtdh_QlxZS2GZN0cP69HerKhau3Offy7iHkmkJGgZZ3Xda3IWPAaEZpLQBOyIpWok6hzOkpWQGwIs0Z8HNyEUIHAJyLfEXyzTBMoxucnnoVnT8katQJHqKL7ttiojDavY3WhMS1iZl2n66_JGet6oO5-r1r8vH89P74mm7fXjaPD9sUc17FlBac0oYxqivBFebQVICG1dCUtWgqo0vEFhVWrWg16qaoSyYqpmvkZa1Kka_J7dK78-5rMiHKwQY0fa9G46YgGS-AHyfXM3rzB-3c5Mf5u5nivKwEnUWsCV0o9C4Eb1q583ZQ_iApyKNG2clZozx2ykXjnLlfMmZeurfGy4DWjGi09Qaj1M7-k_4ByO55sg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555687106</pqid></control><display><type>article</type><title>Immunomodulatory and cytotoxic activities of euphol</title><source>Elsevier ScienceDirect Journals Complete</source><creator>de Oliveira, Thais Latansio ; Bavia, Lorena ; Fontana, Pâmela Dias ; Cruz, Luiza Stolz ; Paludo, Katia Sabrina ; Crisma, Amanda Rabello ; Messias-Reason, Iara Jose ; Beltrame, Flávio Luís</creator><creatorcontrib>de Oliveira, Thais Latansio ; Bavia, Lorena ; Fontana, Pâmela Dias ; Cruz, Luiza Stolz ; Paludo, Katia Sabrina ; Crisma, Amanda Rabello ; Messias-Reason, Iara Jose ; Beltrame, Flávio Luís</creatorcontrib><description>This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines.
CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining.
Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines.
Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment.
[Display omitted]
•Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2021.119700</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Addictions ; Apoptosis ; Cell death ; Cell morphology ; Chemotaxis ; Chromatin ; Complement ; Complement activation ; Complement system ; Cytology ; Cytotoxicity ; Enzyme-linked immunosorbent assay ; Euphorbia umbellata ; Evaluation ; Immunomodulation ; Inflammation ; Inflammatory diseases ; Latex ; Leukocyte migration ; Leukocytes (neutrophilic) ; Monoclonal antibodies ; Morphology ; Mortality ; Neutrophils ; Rounding ; Toxicity</subject><ispartof>Life sciences (1973), 2021-09, Vol.280, p.119700-119700, Article 119700</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright Elsevier BV Sep 1, 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</citedby><cites>FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lfs.2021.119700$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>de Oliveira, Thais Latansio</creatorcontrib><creatorcontrib>Bavia, Lorena</creatorcontrib><creatorcontrib>Fontana, Pâmela Dias</creatorcontrib><creatorcontrib>Cruz, Luiza Stolz</creatorcontrib><creatorcontrib>Paludo, Katia Sabrina</creatorcontrib><creatorcontrib>Crisma, Amanda Rabello</creatorcontrib><creatorcontrib>Messias-Reason, Iara Jose</creatorcontrib><creatorcontrib>Beltrame, Flávio Luís</creatorcontrib><title>Immunomodulatory and cytotoxic activities of euphol</title><title>Life sciences (1973)</title><description>This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines.
CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining.
Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines.
Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment.
[Display omitted]
•Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases.</description><subject>Addictions</subject><subject>Apoptosis</subject><subject>Cell death</subject><subject>Cell morphology</subject><subject>Chemotaxis</subject><subject>Chromatin</subject><subject>Complement</subject><subject>Complement activation</subject><subject>Complement system</subject><subject>Cytology</subject><subject>Cytotoxicity</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Euphorbia umbellata</subject><subject>Evaluation</subject><subject>Immunomodulation</subject><subject>Inflammation</subject><subject>Inflammatory diseases</subject><subject>Latex</subject><subject>Leukocyte migration</subject><subject>Leukocytes (neutrophilic)</subject><subject>Monoclonal antibodies</subject><subject>Morphology</subject><subject>Mortality</subject><subject>Neutrophils</subject><subject>Rounding</subject><subject>Toxicity</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAURYMoOI7-AHcFN25aX9KmaXEl4sfAgBtdh_QlxZS2GZN0cP69HerKhau3Offy7iHkmkJGgZZ3Xda3IWPAaEZpLQBOyIpWok6hzOkpWQGwIs0Z8HNyEUIHAJyLfEXyzTBMoxucnnoVnT8katQJHqKL7ttiojDavY3WhMS1iZl2n66_JGet6oO5-r1r8vH89P74mm7fXjaPD9sUc17FlBac0oYxqivBFebQVICG1dCUtWgqo0vEFhVWrWg16qaoSyYqpmvkZa1Kka_J7dK78-5rMiHKwQY0fa9G46YgGS-AHyfXM3rzB-3c5Mf5u5nivKwEnUWsCV0o9C4Eb1q583ZQ_iApyKNG2clZozx2ykXjnLlfMmZeurfGy4DWjGi09Qaj1M7-k_4ByO55sg</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>de Oliveira, Thais Latansio</creator><creator>Bavia, Lorena</creator><creator>Fontana, Pâmela Dias</creator><creator>Cruz, Luiza Stolz</creator><creator>Paludo, Katia Sabrina</creator><creator>Crisma, Amanda Rabello</creator><creator>Messias-Reason, Iara Jose</creator><creator>Beltrame, Flávio Luís</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20210901</creationdate><title>Immunomodulatory and cytotoxic activities of euphol</title><author>de Oliveira, Thais Latansio ; Bavia, Lorena ; Fontana, Pâmela Dias ; Cruz, Luiza Stolz ; Paludo, Katia Sabrina ; Crisma, Amanda Rabello ; Messias-Reason, Iara Jose ; Beltrame, Flávio Luís</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Addictions</topic><topic>Apoptosis</topic><topic>Cell death</topic><topic>Cell morphology</topic><topic>Chemotaxis</topic><topic>Chromatin</topic><topic>Complement</topic><topic>Complement activation</topic><topic>Complement system</topic><topic>Cytology</topic><topic>Cytotoxicity</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Euphorbia umbellata</topic><topic>Evaluation</topic><topic>Immunomodulation</topic><topic>Inflammation</topic><topic>Inflammatory diseases</topic><topic>Latex</topic><topic>Leukocyte migration</topic><topic>Leukocytes (neutrophilic)</topic><topic>Monoclonal antibodies</topic><topic>Morphology</topic><topic>Mortality</topic><topic>Neutrophils</topic><topic>Rounding</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Oliveira, Thais Latansio</creatorcontrib><creatorcontrib>Bavia, Lorena</creatorcontrib><creatorcontrib>Fontana, Pâmela Dias</creatorcontrib><creatorcontrib>Cruz, Luiza Stolz</creatorcontrib><creatorcontrib>Paludo, Katia Sabrina</creatorcontrib><creatorcontrib>Crisma, Amanda Rabello</creatorcontrib><creatorcontrib>Messias-Reason, Iara Jose</creatorcontrib><creatorcontrib>Beltrame, Flávio Luís</creatorcontrib><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Oliveira, Thais Latansio</au><au>Bavia, Lorena</au><au>Fontana, Pâmela Dias</au><au>Cruz, Luiza Stolz</au><au>Paludo, Katia Sabrina</au><au>Crisma, Amanda Rabello</au><au>Messias-Reason, Iara Jose</au><au>Beltrame, Flávio Luís</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunomodulatory and cytotoxic activities of euphol</atitle><jtitle>Life sciences (1973)</jtitle><date>2021-09-01</date><risdate>2021</risdate><volume>280</volume><spage>119700</spage><epage>119700</epage><pages>119700-119700</pages><artnum>119700</artnum><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines.
CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining.
Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines.
Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment.
[Display omitted]
•Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.lfs.2021.119700</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0024-3205 |
ispartof | Life sciences (1973), 2021-09, Vol.280, p.119700-119700, Article 119700 |
issn | 0024-3205 1879-0631 |
language | eng |
recordid | cdi_proquest_miscellaneous_2540520219 |
source | Elsevier ScienceDirect Journals Complete |
subjects | Addictions Apoptosis Cell death Cell morphology Chemotaxis Chromatin Complement Complement activation Complement system Cytology Cytotoxicity Enzyme-linked immunosorbent assay Euphorbia umbellata Evaluation Immunomodulation Inflammation Inflammatory diseases Latex Leukocyte migration Leukocytes (neutrophilic) Monoclonal antibodies Morphology Mortality Neutrophils Rounding Toxicity |
title | Immunomodulatory and cytotoxic activities of euphol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A00%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunomodulatory%20and%20cytotoxic%20activities%20of%20euphol&rft.jtitle=Life%20sciences%20(1973)&rft.au=de%20Oliveira,%20Thais%20Latansio&rft.date=2021-09-01&rft.volume=280&rft.spage=119700&rft.epage=119700&rft.pages=119700-119700&rft.artnum=119700&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2021.119700&rft_dat=%3Cproquest_cross%3E2540520219%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555687106&rft_id=info:pmid/&rft_els_id=S002432052100686X&rfr_iscdi=true |